1. Home
  2. KYMR

KYMR

Kymera Therapeutics Inc.

Logo Kymera Therapeutics Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Founded: 2015 Country:
United States
United States
Employees: N/A City: WATERTOWN
Market Cap: 2.4B IPO Year: 2020
Target Price: $39.70 AVG Volume (30 days): 691.8K
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.52 EPS Growth: N/A
52 Week Low/High: $9.60 - $45.31 Next Earning Date: 05-02-2024
Revenue: $78,592,000 Revenue Growth: 67.84%
Revenue Growth (this year): -23.84% Revenue Growth (next year): 24.04%

Share on Social Networks: